Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approximately 3 Years after a Booster Vaccination with FSME-IMMUN 0.25 ml Junior in Children

Registry ID

EUCTR2005-000768-19

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Baxter Vaccine AG

Start date

2005-08-02

Completion date

2006-07-05

Last update

2026-08-16

Conditions

• Tick-borne encephalitis

Summary

Seropositivity rate, measured by ELISA and/or NT (according to Adner et al., 2001), approximately 3 years after the first booster vaccination with FSME-IMMUN 0.25 ml Junior

Locations

• , , Austria

View on source registry